CATEGORY

Business

Nikola’s Wild Week Erases EV Maker’s 75% Wipeout in 2023

(Bloomberg) -- Nikola Corp. has finally reignited some of the fervor of its once die hard day-trading fans.Most Read from BloombergThe electric-vehicle maker...

These 2 Biotech Stocks Are Most Likely to Be Acquired, Says Needham — and They Have Over 60% Upside Potential

Biotech stocks make for an interesting study. They represent a high-risk sector, characterized by famously high overhead and long lead times to develop...

Top CD Rates Today, July 14, 2023

For the first time in a long while, the news for CD shoppers is worse today than yesterday, though the change is minor:...

The ‘Everything Rally’ Is Back. So Is the Casino Crowd

(Bloomberg) -- The long-awaited broadening in the 2023 equity advance is bringing gains to corners of the market even unabashed bulls may view...

Investors Can Still Get Into Four IBD 50 Leaders, Including Uber Stock

Sometimes you miss a chance to buy a great growth stock but follow-on opportunities emerge. A simple chart tool — the 10-week moving...

Week’s Best: Schwab Rolls Out Perks for Wealthy Customers

Charles Schwab is adding services for retail clients who have account balances of more than $1...

AT&T Falls to 29-Year Low Amid Concerns of Cleanup Costs

(Bloomberg) -- AT&T Inc. shares hit an almost three-decade low Friday amid growing concerns of the potentially high costs the phone giant faces...

AT&T Falls to 29-Year Low Amid Concerns of Cleanup Costs

(Bloomberg) -- AT&T Inc. shares hit an almost three-decade low Friday amid growing concerns of the potentially high costs the phone giant faces...

Top Biotech Obliterates Sales Estimates And Soars To Two-Year High

Acadia Pharmaceuticals (ACAD) obliterated Wall Street's expectations for the launch quarter of its Rett syndrome treatment and, on Friday, ACAD stock hit a...

Latest news